Focused Atorvastatin Therapy in Managed-Care Patients With Coronary Heart Disease and CKD

Patients with CHD and CKD are at increased risk of cardiovascular events. Compared with usual care, focused atorvastatin treatment decreased cardiovascular risk for established patients in real-world settings, with no significant difference in treatment effects observed between patients with and without CKD.